reglab/statecodes huggingface dataset:
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter A - Medications Used in the Treatment of Obesity › Section XLV-6913 - Effect of Violation

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any
					 violation of or failure of compliance with the provisions of this Subchapter,
					 §§6901-6913, shall be deemed a violation of
					 R.S.
					 37:1285.A(6) and (29), providing cause for
					 the board to suspend or revoke, refuse to issue, or impose probationary or
					 other restrictions on any license or permit held or applied for by a physician
					 culpable of such violation.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6),
						and
						37:1285(B).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter B - Medications Used in the Treatment of Non-Cancer-Related Chronic or Intractable Pain › Section XLV-6915 - Scope of Subchapter

Current through Register Vol. 50, No. 6, June 20, 2024
A. The
					 rules of this Subchapter govern physician responsibility for providing
					 effective and safe pain control for patients with noncancer-related chronic or
					 intractable pain.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and 1285(B).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter B - Medications Used in the Treatment of Non-Cancer-Related Chronic or Intractable Pain › Section XLV-6919 - General Conditions/Prohibitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. The treatment of noncancer-related chronic
					 or intractable pain with controlled substances constitutes legitimate medical
					 therapy when provided in the course of professional medical practice and when
					 fully documented in the patient's medical record. A physician duly authorized
					 to practice medicine in Louisiana and to prescribe controlled substances in
					 this state shall not, however, prescribe, dispense, administer, supply, sell,
					 give, or otherwise use for the purpose of treating such pain, any controlled
					 substance unless done in strict compliance with applicable state and federal
					 laws and the rules enumerated in this Subchapter.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6)
						and
						37:1285(B).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter B - Medications Used in the Treatment of Non-Cancer-Related Chronic or Intractable Pain › Section XLV-6921 - Use of Controlled Substances, Limitations

Current through Register Vol. 50, No. 6, June 20, 2024
A. Requisite Prior Conditions. In utilizing
					 any controlled substance for the treatment of noncancer-related chronic or
					 intractable pain on a protracted basis, a physician shall comply with the
					 following rules.
1. Evaluation of the
					 Patient. Evaluation of the patient shall initially include relevant medical,
					 pain, alcohol and substance abuse histories, an assessment of the impact of
					 pain on the patient's physical and psychological functions, a review of
					 previous diagnostic studies, previously utilized therapies, an assessment of
					 coexisting illnesses, diseases, or conditions, and an appropriate physical
					 examination.
2. Medical Diagnosis.
					 A medical diagnosis shall be established and fully documented in the patient's
					 medical record, which indicates not only the presence of noncancer-related
					 chronic or intractable pain, but also the nature of the underlying disease and
					 pain mechanism if such are determinable.
3. Treatment Plan. An individualized
					 treatment plan shall be formulated and documented in the patient's medical
					 record which includes medical justification for controlled substance therapy.
					 Such plan shall include documentation that other medically reasonable
					 alternative treatments for relief of the patient's noncancer-related chronic or
					 intractable pain have been considered or attempted without adequate or
					 reasonable success. Such plan shall specify the intended role of controlled
					 substance therapy within the overall plan, which therapy shall be tailored to
					 the individual medical needs of each patient.
4. Informed Consent. A physician shall ensure
					 that the patient and/or his guardian is informed of the benefits and risks of
					 controlled substance therapy. Discussions of risks and benefits should be noted
					 in some format in the patient's record.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter B - Medications Used in the Treatment of Non-Cancer-Related Chronic or Intractable Pain › Section XLV-6923 - Effect of Violation

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any
					 violation of or failure of compliance with the provisions of this Subchapter,
					 §§6915-6923, shall be deemed a violation of
					 R.S.
					 37:1285.A(6) and (14), providing cause for
					 the board to suspend or revoke, refuse to issue, or impose probationary or
					 other restrictions on any license held or applied for by a physician to
					 practice medicine in the state of Louisiana culpable of such
					 violation.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6),
						and
						37:1285(B).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter C - Mandatory Access and Review of Prescription Monitoring Program Data › Section XLV-6931 - Scope of Subchapter

Current through Register Vol. 50, No. 6, June 20, 2024
A. The
					 rules of this Subchapter provide for prescriber mandatory access and review of
					 the Louisiana Prescription Monitoring Program,
					 R.S.
					 40:1001 et seq., as from time-to-time may be
					 amended (PMP), and for exceptions and noncompliance.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270, 37:611-37:628, 37:1360.23, and
						40:978.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter C - Mandatory Access and Review of Prescription Monitoring Program Data › Section XLV-6933 - Definitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. As used in this Subchapter, the following terms and
						phrases shall have the meanings specified.
Administer-
with respect to a medication
						provided or dispensed by a prescriber for use by a patient, the term
administer
means directly or through an agent to give,
						provide, or supply for immediate oral ingestion, insertion, or topical
						application by the patient, or to insert, apply topically, or inject
						intravenously, intramuscularly, subcutaneously, intrathecally, or
						extrathecally.
Board-
the Louisiana State Board of
						Medical Examiners, as constituted under
						R.S.
						37:1263.
Controlled Dangerous Substance-
any
						substance defined, enumerated or included in federal or state statute or
						regulations  21 CFR §§ 1308.11-15  or
						R.S.
						40:964, or any substance which may hereafter
						be designated as a controlled substance by amendment or supplementation of such
						regulations and statute.
Delegate-
an individual authorized by a
						prescriber or dispenser who is also authorized to access and retrieve
						prescription monitoring program data for the purpose of assisting the
						prescriber or dispenser, and for whose actions the authorizing prescriber or
						dispenser retains accountability.
Prescribe-
to issue a request or order
						for a drug or medical device by an individual licensed under this Part for a
						legitimate medical purpose. The act of prescribing must be in good faith and in
						the usual course of the licensee's professional practice.
Prescriber-
a physician, podiatrist,
						physician assistant, and any other category of health care provider as may
						hereafter be licensed by the board under this Part, whose scope of practice
						includes authority to prescribe opioids.
Prescription-
an order from a
						practitioner authorized by law to prescribe for a drug or device that is
						patient specific and is communicated by any means to a pharmacist in a
						permitted pharmacy
Prescription Monitoring Program or PMP-
the electronic system for the monitoring of controlled substances and other
						drugs of concern established by the Prescription Monitoring Program Act,
						R.S.
						40:1001 et seq., as may from time-to-time be
						amended.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270, 37:611-37:628, 37:1360.23, and
						40:978.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter C - Mandatory Access and Review of Prescription Monitoring Program Data › Section XLV-6935 - Mandatory Access and Review of Prescription Monitoring Program Data; Exceptions

Current through Register Vol. 50, No. 6, June 20, 2024
A. Prior to
					 initially prescribing any opioid to a patient, a prescriber or his/her delegate
					 shall access and review the patients record in the PMP; and
B. If opioids are prescribed to the patient
					 for more than 90 days, the prescriber or his/her delegate shall access and
					 review the record in the PMP at least every 90 days.
C. This Section shall not apply if:
1. the drug is prescribed or administered to
					 a hospice patient or any other patient who has been diagnosed as terminally
					 ill;
2. the drug is prescribed or
					 administered for the treatment of cancer-related chronic or intractable
					 pain;
3. the drug is ordered or
					 administered to a patient being treated in a hospital;
4. the PMP is not accessible or not
					 functioning properly due to an electronic issue. However, the prescriber shall
					 check the PMP after electronic accessibility has been restored and note the
					 cause for the delay in the patients chart; or
5. no more than a single seven-day supply of
					 the drug is prescribed or administered to a patient.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter C - Mandatory Access and Review of Prescription Monitoring Program Data › Section XLV-6937 - Effect of Non-Compliance

Current through Register Vol. 50, No. 6, June 20, 2024
A. For
					 non-compliance with any of the provisions of this Subchapter the board may
					 suspend, revoke, refuse to issue or impose probationary or other terms,
					 conditions and restrictions on any license to practice in the state of
					 Louisiana, or any registration issued under this Part, held or applied for by:
1. a physician culpable of such violation
					 under
					 R.S.
					 37:1285(A);
2. a podiatrist culpable of such violation
					 under
					 R.S.
					 37:624(A); and
3. a physician assistant culpable of such
					 violation under
					 R.S.
					 37:1360.33.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter A - General Provisions › Section XLV-7101 - Scope of Chapter

Current through Register Vol. 50, No. 6, June 20, 2024
A. The rules of
					 this Chapter govern physician use of integrative or complementary medicine in
					 the treatment of patients.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter A - General Provisions › Section XLV-7103 - Definitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. As used in this
					 Chapter, unless the content clearly states otherwise, the following terms and
					 phrases shall have the meanings specified.
Board
- the Louisiana State Board of
						Medical Examiners.
Controlled Substance
- any substance
						defined, enumerated or included in federal or state regulations or statute  21
						CFR 1308.11-15  or
						R.S.
						40:964, or any substance which may hereafter
						be designated as a controlled substance by amendment or supplementation of such
						regulations or statute.
Conventional or Conventional Medicine
-
						diagnostic methods or therapies offered or employed by a physician, or under
						his on-site supervision and direction, in the diagnosis, prevention or
						treatment of any illness, disease or condition which are generally accepted and
						recognized as falling within the standard of care in the course of medical
						practice based upon medical training, experience and peer reviewed scientific
						literature.
Integrative or Complementary Medicine
-
						diagnostic methods or therapies offered or employed by a physician, or under
						his on-site supervision and direction, in addition or as an alternative to
						conventional medicine methods or therapies, in the diagnosis, prevention or
						treatment of any illness, disease or condition which do not, in the judgment of
						the physician, pose a safety risk for a patient that is greater than
						conventional medicine methods or therapies and provided there exists a
						reasonable probability for diagnostic or therapeutic effectiveness in its
						intended use. Integrative or complementary medicine does not include the use of
						controlled substances in the treatment of patients suffering from chemical
						dependency.
On-Site Supervision and Direction
-
						medical functions or procedures performed under physician supervision and
						direction by an appropriately trained and qualified non-physician in the course
						and scope of his or her employment or contractual relationship with a
						physician, when such physician is physically present on the premises at all
						times that such non-physician is on duty and retains full responsibility to
						patients and the board for the manner and results of all services rendered.
						On-site supervision and direction shall not be construed under any
						circumstances to permit a non-physician to act independently of a physician or
						exercise independent medical judgment in rendering a diagnosis, prescribing
						medication or in implementing modalities of diagnosis or treatment.
Physician
- a person possessing a current
						license issued by the board to practice medicine in the state of
						Louisiana.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter A - General Provisions › Section XLV-7105 - General Conditions/Prohibitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. The use of integrative or complementary
					 medicine for the diagnosis or treatment of any illness, disease or condition,
					 constitutes legitimate medical therapy when provided in the course of
					 professional medical practice, complies with the standard of care applicable to
					 conventional medicine practitioners, and when fully documented in the patient's
					 medical record. Any physician utilizing integrative or complementary medicine
					 shall do so in strict compliance with the rules enumerated in this
					 Chapter.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter A - General Provisions › Section XLV-7107 - Use of Integrative or Complementary Medicine; Limitations

Current through Register Vol. 50, No. 6, June 20, 2024
A. Requisite Prior
					 Conditions. Any physician offering or utilizing integrative or complementary
					 medicine shall comply with the following rules.
1. Evaluation of the Patient. Prior to
					 offering integrative or complementary medicine a physician shall perform an
					 evaluation of the patient that shall include but not be limited to any
					 conventional methods of diagnosis which, in the judgment of the physician, are
					 deemed necessary or appropriate to the condition of the patient. Such an
					 evaluation shall include:
a. a relevant
					 medical history;
b. an appropriate
					 physical examination; and
c. a
					 review of the results of any relevant diagnostic studies or therapies
					 undertaken or previously attempted.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter A - General Provisions › Section XLV-7109 - Effect of Violation

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any
					 violation or failure of compliance with the provisions of this Chapter, shall
					 be deemed unprofessional conduct and conduct in contravention of the board's
					 rules, in violation of
					 R.S.
					 37:1285.A(13) and (30) respectively, as well
					 as violation of any other applicable provision of
					 R.S.
					 37:1285.A, providing cause for the board to
					 suspend, revoke, refuse to issue, or impose probationary or other restrictions
					 on any license held or applied for by a physician to practice medicine in the
					 state of Louisiana culpable of such violation.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 71 - Integrative and Complementary Medicine › Subchapter B - Integrative or Complementary Medicine Advisory Committee › Section XLV-7111 - Organization, Authority and Responsibilities

Current through Register Vol. 50, No. 6, June 20, 2024
A. Constitution. An Integrative and
					 Complementary Medicine Advisory Committee (the "advisory committee") to the
					 board is hereby constituted to be composed, appointed and to have such
					 functions as hereinafter provided.
B. Composition and Qualifications. The
					 advisory committee shall be comprised of up to five physicians each of whom
					 shall be in good standing with the board, have practiced and resided within the
					 state of Louisiana for not less than one year, possess experience in and have
					 specialized in integrative or complementary medicine for not less than three
					 years.
C. Appointment; Term of
					 Service. Of the board's initial appointments, two members of the advisory
					 committee will be appointed to serve terms expiring on the last day of the year
					 of appointment with the remaining members to serve terms expiring on the last
					 day of the year succeeding the year of appointment. Thereafter, each member of
					 the advisory committee shall serve a term of two years or until his or her
					 successor is appointed. Advisory committee members shall be eligible for
					 reappointment. All members of the advisory committee shall serve and be subject
					 to removal at any time at the pleasure of the board. Members appointed to the
					 advisory committee to fill a vacancy occurring other than by expiration of the
					 designated term shall serve for the unexpired term. Other than the initial
					 appointments provided for herein, board appointments to the advisory committee
					 shall be effective when made with respect to appointments for unexpired terms
					 and otherwise shall be effective as of the first day of the year following the
					 date of appointment.
D. Functions
					 and Responsibilities of the Committee. The advisory committee is responsible
					 and authorized by the board to:
1. provide
					 advice and recommendations to the board respecting the modification, amendment
					 and supplementation of rules and regulations, standards of care and policies
					 and procedures respecting integrative or complementary medicine;
2. advise, assist and provide the board with
					 such information and expertise as it may request and upon which it may rely,
					 with respect to investigative and/or disciplinary proceedings affecting
					 physicians utilizing integrative or complementary medicine;
3. serve as a liaison between the board and
					 physicians practicing integrative or complementary medicine;
4. perform such other functions and provide
					 such additional advice and recommendations as may be requested by the board;
					 and
5. receive reimbursement for
					 attendance at board meetings and for other expenses when specifically
					 authorized by the board.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7201 - Preamble and Scope of Subchapter

Current through Register Vol. 50, No. 6, June 20, 2024
A.
					 Pursuant to Act 11 of the 2004 session of the Louisiana Legislature, the
					 Louisiana Psychology Practice Act was amended to include, among other items,
					 R.S.
					 37:2375 C(1), which provides: "A medical
					 psychologist holding a valid certificate to prescribe shall prescribe only in
					 consultation and collaboration with the patient's primary or attending
					 physician, and with the concurrence of that physician. The medical psychologist
					 shall also re-consult with the patient's physician prior to making changes in
					 the patient's medication regimen, including dosage adjustments, adding or
					 discontinuing a medication. The medical psychologist and the physician shall
					 document the consultation in the patient's medical record."
B. Pursuant to the authority granted by
					 R.S.
					 37:1270(B)(6), and in the
					 interest of promoting the public health, safety, and welfare, the rules of this
					 Chapter are adopted by the Louisiana State Board of Medical Examiners to govern
					 the practice of physicians in this state who consult and collaborate with a
					 medical psychologist with respect to a patient of the physician.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and 37:2371-2378.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7205 - General Conditions

Current through Register Vol. 50, No. 6, June 20, 2024
A. A
					 physician shall only consult and collaborate with an MP provided such is
					 performed in the course of his or her professional practice, documented in the
					 patient's medical record, and in compliance with all of the requirements
					 specified by this Chapter.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270,
						37:1360.51-1360.72.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7207 - General Prohibitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. A
					 physician shall not consult and collaborate, as defined in
					 §7203 of these rules:
1. if the physician is no longer engaged in
					 the clinical practice of medicine and the provision of patient care in this
					 state;
2. on any patient for whom
					 the physician is not the primary or attending physician;
3. with a psychologist who is not an
					 MP;
4. with more than one MP on the
					 same patient;
5. if he or she is
					 aware that more than one primary or attending physician is consulting or
					 collaborating with the MP on the same patient at the same time;
6. with respect to the treatment of any
					 condition other than mental and emotional disorders;
7. with respect to controlled substances if
					 the physician's controlled substance privileges, registration or permit has
					 been suspended, revoked or restricted by the board or other state or federal
					 authorities;
8. with respect to
					 narcotics; or
9. with an MP who
					 seeks to utilize controlled substances for the treatment of:
a. non-cancer related chronic or intractable
					 pain, as set forth in §6915-6923 of the board's rules; or
b. obesity, as set forth in §6901-6913 of the
					 board's rules.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7209 - Authority, Responsibility and Limitations

Current through Register Vol. 50, No. 6, June 20, 2024
A. Consultation and Collaboration.
					 Consultation and collaboration shall include discussion of any item the
					 physician considers relevant to the coordination of the patient's medical care
					 or evaluation of the psychopharmacologic management planned by the MP. The
					 physician's consultation shall be documented in the patient's medical record
					 and include, at a minimum:
1. Patient
					 Authorization. A physician shall not consult and collaborate without the
					 patient's written authorization to provide and/or receive from the MP any
					 documents or records the physician may deem necessary throughout the course of
					 psychopharmacologic management. A physician shall either obtain such
					 authorization directly or document the MP's verification that the MP has done
					 so and request and obtain a copy for his medical record on the
					 patient;
2. Patient Identity, Date
					 and Parties. The patient's name, current addresses and telephone number; the
					 date of the consult; and the MP's name and telephone number shall be clearly
					 identified. If the physician is unfamiliar with the MP, the physician shall
					 also verify that the MP holds a current certificate of prescriptive
					 authority;
3. Purpose. The purpose
					 for the consult (e.g., new medication; change in medication; discontinuance of
					 medication; adverse treatment effects; treatment failure; change in mental
					 status; etc.);
4. Psychological
					 Evaluation and Diagnosis. If known, the MP's psychological evaluation of the
					 patient, including any relevant psychological history, laboratory or diagnostic
					 studies; the MP's psychological diagnosis; and any other information the
					 physician may deem necessary for the coordination of medical care of the
					 patient;
5. Medication. The
					 specific drug(s) the MP plans to utilize, including the starting dosage and
					 titration plan, if any; frequency of use; the number of refills and anticipated
					 duration of therapy; relevant indications and contraindications; any previously
					 utilized psychopharmacologic therapy; and any alternatives;
6. Treatment Plan. The MPs treatment and/or
					 management plan for the patient;
7.
					 Results of Consultation. The results of the consultation (e.g., concurrence,
					 deferring or denying medication recommended by the MP);
8. Responsibilities. Any specific
					 responsibilities of the physician and MP respecting the patient's
					 care;
9. Reporting. Any reporting
					 and documentation requirements the physician may request of the MP and/or a
					 schedule by which such are to take place; and
10. Immediate Consultation. A plan to
					 accommodate immediate consultation between the physician, MP and/or the
					 patient.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7211 - Withdrawal or Termination of Concurrence

Current through Register Vol. 50, No. 6, June 20, 2024
A. A physician shall notify an MP and his
					 patient in a timely manner that he or she has withdrawn or terminated
					 concurrence if:
1. the physician determines
					 that the medication prescribed is no longer appropriate or is
					 contraindicated;
2. the physician
					 receives information indicating that the patient is non-compliant with the
					 treatment prescribed and questions relating to such non compliance cannot be
					 addressed satisfactorily upon further consultation with the MP;
3. the MP fails or refuses to provide
					 requested documentation or other information that may impact the physician's
					 decision to concur or continue to concur in the psychopharmacologic management
					 planned by the MP;
4. adjustments
					 or changes were made to the patient's psychopharmacologic management by the MP
					 without consultation and collaboration;
5. the physician becomes aware of information
					 that would prohibit consultation and collaboration under
					 §7207 of this Chapter;
6. the physician is advised of the patient's
					 election to withdraw from psychopharmacologic management by an MP, or to
					 withdraw his or her authority for the physician or the MP to consult and
					 collaborate;
7. the physician
					 retires or withdraws from clinical practice in this state or relocates his or
					 her practice to a location that would render continuing care of the patient
					 impractical; or
8. the physician's
					 license is suspended, revoked or restricted in a manner that would prohibit
					 consulting and collaborating with an MP.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7213 - Informed Consent

Current through Register Vol. 50, No. 6, June 20, 2024
A. A physician
					 shall not consult and collaborate with an MP without the patient's written
					 authorization as set forth in Subparagraph 7209.A.1.
B. A physician shall insure that each of his
					 or her patients subject to consultation and collaboration with an MP is
					 informed:
1. of the relationship between the
					 physician and MP and the respective role of each with respect to the patient's
					 psychopharmacologic management;
2.
					 that he or she may decline to participate in such a practice and may withdraw
					 at any time without terminating the physician-patient relationship;
3. of the physician's decision to deny or
					 withdraw from consultation and collaboration with an MP; and
4. by written disclosure, of any contractual
					 or financial arrangement that may impact the physician's decision to engage in
					 consultation and collaboration with an MP.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7215 - Reporting Obligations

Current through Register Vol. 50, No. 6, June 20, 2024
A. A
					 physician who consults and collaborates with a MP should report to the board
					 all instances in which he or she has a good faith reason to believe that the MP
					 has:
1. failed to consult with the primary or
					 attending physician prior to prescribing medication or making any adjustments
					 or changes in an established medication regimen;
2. prescribed a narcotic, as defined in
					 R.S.
					 40:961;
3. treated any condition, illness or disease
					 other than management of mental or emotional disorders; or
4. prescribed a course of medication that
					 resulted in the injury or death of a patient.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 72 - Consultation or Collaboration with Medical Psychologists › Subchapter A - General Provisions › Section XLV-7217 - Action against Medical License

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any violation or failure to comply with
					 the provisions of this Chapter shall be deemed unprofessional conduct and
					 conduct in contravention of the board's rules, in violation of
					 R.S.
					 37:1285(A)(13) and (30),
					 respectively, as well as violation of any other applicable provision of
					 R.S.
					 37:1285(A), providing cause
					 for the board to suspend, revoke, refuse to issue or impose probationary or
					 other restrictions on any license held or applied for by a physician culpable
					 of such violation.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and 1285.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7301 - Scope of Chapter

Current through Register Vol. 50, No. 6, June 20, 2024
A. The rules of
					 this Chapter govern the performance of office-based surgery by physicians in
					 this state.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7305 - Exemptions

Current through Register Vol. 50, No. 6, June 20, 2024
A. This Chapter
					 shall not apply to the following surgical procedures or clinical settings:
1. exempt surgical procedures include those:
a. that do not involve a drug induced
					 alteration of consciousness and do not require the use of anesthesia or an
					 anesthetic agent, those using only local, topical or regional anesthesia or
					 those using a single oral dose of a sedative or analgesic which is appropriate
					 for the unsupervised treatment of anxiety or pain; and/or
b. performed by a physician oral and
					 maxillofacial surgeon under the authority and within the scope of a license to
					 practice dentistry issued by the Louisiana State Board of Dentistry;
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7307 - Prohibitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. On and after
					 January 1, 2005, no physician shall perform office-based surgery except in
					 compliance with the rules of this Chapter.
B. The level of sedation utilized for
					 office-based surgery shall be appropriate to the procedure. Under no
					 circumstances shall a physician withhold appropriate sedation or under-sedate a
					 patient for the purpose of avoiding compliance with the requirements of this
					 Chapter.
C. General anesthesia
					 shall not be utilized in office-based surgery. Any surgery or surgical
					 procedure that employs general anesthesia shall only be performed in an
					 exempted clinical setting as described in
					 Section
					 7305 of this
					 Chapter.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7308 - Required Information

Current through Register Vol. 50, No. 6, June 20, 2024
A. Each
					 physician shall report to the board annually as a condition to the issuance or
					 renewal of medical licensure, whether or not and the location(s) where the
					 physician performs office-based surgery, along with such other information as
					 the board may request.
B. The
					 information shall be reported in a format prepared by the board, which shall be
					 made a part of or accompany each physicians renewal application for medical
					 licensure.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7309 - Prerequisite Conditions

Current through Register Vol. 50, No. 6, June 20, 2024
A. A
					 physician who performs office-based surgery shall adhere to and comply with the
					 following rules.
1. Facility and Safety
a. The facility shall comply with all
					 applicable federal, state and local laws, codes and regulations pertaining to
					 fire prevention, building construction and occupancy, accommodations for the
					 disabled, occupational safety and health, medical waste and hazardous waste,
					 infection control and storage and administration of controlled
					 substances.
b. All premises shall
					 be kept neat and clean. Operating areas shall be sanitized and materials,
					 instruments, accessories and equipment shall be sterilized.
c. Supplies of appropriate sterile linens,
					 gloves and dressings shall be maintained in sufficient quantities for routine
					 and emergency use. All surgical personnel shall wear suitable operative
					 attire.
d. Supplies of appropriate
					 drugs, medications and fluids shall be maintained in sufficient quantities for
					 routine and emergency use.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7311 - Administration of Anesthesia

Current through Register Vol. 50, No. 6, June 20, 2024
A.
					 Evaluation of the Patient. All patients shall have a pre-surgical evaluation
					 (history and physical) to screen for and identify any medical condition that
					 could adversely affect the patients response to the medications utilized for
					 moderate or deep sedation.
B.
					 Diagnostic Testing, Consultations. Appropriate pre-anesthesia diagnostic
					 testing and consults shall be obtained as indicated by the pre-anesthesia
					 evaluation.
C. Anesthesia Plan of
					 Care. A patient-specific plan for anesthesia care shall be formulated based on
					 the assessment of the patient, the surgery to be performed and the capacities
					 of the facility.
D. Administration
					 of Anesthesia. Deep sedation/analgesia shall be administered by an anesthesia
					 provider who shall not participate in the surgery.
E. Monitoring. Monitoring of the patient
					 shall include continuous monitoring of ventilation, oxygenation and
					 cardiovascular status. Monitors shall include, but not be limited to, pulse
					 oximetry, electrocardiogram continuously, non-invasive blood pressure measured
					 at appropriate intervals, an oxygen analyzer and an end-tidal carbon dioxide
					 analyzer. A means to measure temperature shall be readily available and
					 utilized for continuous monitoring when indicated. An audible signal alarm
					 device capable of detecting disconnection of any component of the breathing
					 system shall be utilized. The patient shall be monitored continuously
					 throughout the duration of the procedure. Post-operatively, the patient shall
					 be evaluated by continuous monitoring and clinical observation until stable.
					 Monitoring and observations shall be documented in the patient's medical
					 record. Qualified monitoring personnel assigned to monitor a patient shall not
					 participate in the surgery.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7313 - Reports to the Board

Current through Register Vol. 50, No. 6, June 20, 2024
A. A
					 physician performing office-based surgery shall notify the board in writing
					 within 15 days of the occurrence or receipt of information that an office-based
					 surgery resulted in:
1. an unanticipated and
					 unplanned transport of the patient from the facility to a hospital emergency
					 department;
2. an unplanned
					 readmission to the office-based surgery setting within 72 hours of discharge
					 from the facility;
3. an
					 unscheduled hospital admission of the patient within 72 hours of discharge from
					 the facility; or
4. the death of
					 the patient within 30 days of surgery in an office-based facility.
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7314 - Creation of Log; Board Access to Log and Facilities

Current through Register Vol. 50, No. 6, June 20, 2024
A. A physician shall create and maintain a
					 continuous log by calendar date of all office-based surgical procedures. The
					 log shall include patient identifiers and the type and duration of each
					 procedure and remain at the physicians office-based surgery facility. The log
					 shall be provided to the boards staff or its agents upon request.
B. A physician who performs office-based
					 surgery shall respond to the inquiries and requests of, and make his or her
					 office-based surgery facility available for inspection by, the board's staff or
					 its agents at any reasonable time without the necessity of prior notice. The
					 failure or refusal to respond or comply with such inquiries or requests, or
					 make an office-based surgery facility available for inspection, shall be deemed
					 a violation of this Chapter.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 73 - Office-Based Surgery › Subchapter A - General Provisions › Section XLV-7315 - Effect of Violation

Current through Register Vol. 50, No. 6, June 20, 2024
A. Any
					 violation or failure to comply with the provisions of this Chapter shall be
					 deemed unprofessional conduct and conduct in contravention of the board's
					 rules, in violation of
					 R.S.
					 37:1285(A)(13) and (30),
					 respectively, as well as violation of any other applicable provision of
					 R.S.
					 37:1285(A), providing cause
					 for the board to suspend, revoke, refuse to issue or impose probationary or
					 other restrictions on any license held or applied for by a physician culpable
					 of such violation.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1),
						37:1270(B)(6).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 74 - Collaborative Drug Therapy Management › Subchapter A - General Provisions › Section XLV-7401 - Scope of Subchapter

Current through Register Vol. 50, No. 6, June 20, 2024
A. The
					 rules of this Chapter govern the registration and practice of physicians
					 engaged in collaborative drug therapy management with pharmacists in this
					 state.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and
						37:1164(37).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 74 - Collaborative Drug Therapy Management › Subchapter B - Prohibitions and Exceptions › Section XLV-7405 - Prohibitions and Exceptions

Current through Register Vol. 50, No. 6, June 20, 2024
A. No
					 physician shall engage in collaborative drug therapy management except in
					 compliance with the rules of this Chapter.
B. This Chapter shall not apply to a
					 physician's practice in a hospital licensed by the Louisiana Department of
					 Health and Hospitals, provided the medication ordered or prescribed by the
					 physician for in-patients of the hospital is managed in accordance with a
					 written agreement approved by the members of the medical staff of the
					 hospital.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and
						37:1164(37).
Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 74 - Collaborative Drug Therapy Management › Subchapter C - Registration › Section XLV-7407 - Eligibility for Registration

Current through Register Vol. 50, No. 6, June 20, 2024
A. No
					 physician shall engage in collaborative drug therapy management in this state
					 until registered with the board in accordance with the provisions of this
					 Subchapter. To be eligible for registration a physician shall, as of the date
					 of the application:
1. possess a current,
					 unrestricted license to practice medicine issued by the board and not be the
					 subject of a pending investigation or complaint by the board or by the medical
					 licensing authority of any other state or jurisdiction;
2. be actively engaged in the clinical
					 practice of medicine and the provision of patient care in this state in the
					 particular field of medicine in which collaborative drug therapy management is
					 to take place; and
3. not be
					 employed by or serve as an independent contractor to a pharmacist, pharmacy, or
					 pharmaceutical company, or be a party to any other or similar employment,
					 contractual or financial relationship. The board may, in its discretion, grant
					 an exception to this requirement on a case-by-case basis where it has been
					 shown to its satisfaction that such relationship is structured so as to
					 prohibit interference or intrusion into the physician's relationship with
					 patients, the exercise of independent medical judgment and satisfaction of the
					 obligations and responsibilities imposed by law or the board's rules on the
					 physician.